HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
RMD
Resmed Inc
Healthcare Medical Instruments & Supplies · California, USA · Reports in usd
Market Cap: $31.21B
Market Cap
$31.21B
Enterprise Val
$30.64B
P/E Ratio
21.00
P/B Ratio
4.94
Trailing PEG (1Y)
1.45
As Of
Apr 29, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q2 2026
Book Value$6.32B
Gross Margin61.76%
Profit Margin61.76%
Return on Equity24.81%
Return on Assets18.26%
Current Ratio3.06
Debt/Equity0.13
LT Debt/Equity0.09
Revenue Per Share9.75

Income Statement

Dec 31, 2025
Revenue$1.42B
Cost of Revenue$544.1M
Gross Profit$878.7M
R&D$91.0M
SG&A$278.4M
Operating Expenses$387.1M
Operating Income$491.7M
Interest Expense-$7.9M
Tax Expense$103.6M
Net Income$392.6M
EPS (Basic)$2.69
EPS (Diluted)$2.68
EBIT$488.2M
EBITDA$550.5M
Consolidated Income$392.6M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$1.42B
Accounts Receivable$985.6M
Inventory$922.0M
Current Assets$3.82B
LT Investments$0.00
Property, Plant & Equipment$730.2M
Intangibles$3.47B
Non-Current Assets$4.68B
Total Assets$8.50B
Accounts Payable$250.4M
Current Debt$289.7M
Current Liabilities$1.25B
LT Debt$558.1M
Non-Current Liabilities$934.4M
Total Liabilities$2.18B
Total Debt$847.7M
Retained Earnings$6.65B
Shareholder Equity$6.32B
Shares Outstanding145,966,294

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$339.7M
Investing Cash Flow-$50.9M
Financing Cash Flow-$258.3M
CapEx-$28.5M
Free Cash Flow$311.2M
Depreciation & Amort.$62.3M
Stock-Based Comp$28.9M
Acquisitions / Disposals$0.00
Investment Activity-$16.4M
Debt Issued/Repaid-$5.0M
Equity Issued/Repaid-$145.5M
Dividends Paid-$87.6M
Net Change in Cash$33.2M
Data cached · Meta live · Daily live · Statements live · TTL 24h